BioTech/Drugs - Seattle, WA, US
Detect and quantify allogeneic cells and DNA at levels of sensitivity unreachable by other detection approaches. Chimerocyte, Inc. uses fluorescent-based real-time quantitative polymerase chain reaction technology for detection. We develop in-house services and create a commercialized kit allowing highly sensitive quantitative chimerism testing for use in clinical diagnostics, as well as for scientific research.
Outlook
Amazon CloudFront
Route 53
WordPress.org
Amazon AWS
Mobile Friendly